Cost benefit analysis of Japanese encephalitis vaccination program in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 28, Issue 1, 1997, Pages 143-148

  Siraprapasiri, Taweesap ^a,c   Sawaddiwudhipong, Witaya ^b   Rojanasuphot, Suntharee ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b MAE SOT GENERAL HOSPITAL   (Thailand)

^c Provincial Health Office   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ARTICLE; CHILD; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; EPIDEMIC ENCEPHALITIS; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; JAPANESE ENCEPHALITIS VIRUS; MALE; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; THAILAND;

CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MALE; THAILAND; VIRAL VACCINES;

EID: 0031089935     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Creese AL, Henderson RH. Cost-benefit analysis and immunization programs in developing countries. Bull WHO 1982; 253:521-9.
2. Hoke CH, Nisalak A, Sangawhipa N, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988; 319: 608-14.
3. Kajornpadungkitti Y, Ungchusak K. Cost benefit analysis of vitamin K for prevention of idiopathic vitamin K deficiency in infancy. Med Council Bull 1988; 17: 198-208.
4. Levine OS, Ortiz E, Contreras R, et al. Cost benefit analysis for the use of Haemophilus influenzae type B conjugate vaccine in Santiago, Chile Am J Epidemiol 1993; 137: 1221-8.
5. Mathurosapas W, Chaikaeo S, Chavanapong W, Chunsuthiwati S. A study of the approaching implementation of Japanese encephalitis vaccination program in Thailand: II. Study of the immune status at different durations of post-vaccinated school children in Chiangmai province, Thailand. Mosq Borne Dis Bull 1989: 6: 31-8.
6. Rojanasuphot S, Na-Chiang Mai P, Srijaggrawalwong A, Panthumachinda B, Nimmanitya S. Implementation of simultaneous Japanese encephalitis vaccination in the expanded program on immunization of infants. Mosq Borne Dis Bull 1992a; 9: 86-92.
7. Rojanasuphot S, Charoensook O, Srijaggrawalwong A, et al. Japanese encephalitis antibody prevalence survey in northern Thailand. Mosq Borne Dis Bull 1992b; 9: 111-18.
8. Sangkawibha N, Rojanasuphot S, Chunsuttiwat S. Epidemiology of Japanse encephalitis and vaccination program in Thailand. Mosq Borne Dis Bull 1992; 9: 1-8.
9. Schoenbaum SC, Hyde JN, Bartoshesky L, Crampton K. Benefit-cost analysis of rubella vaccination policy. N Engl J Med 1976; 294: 306-10.
10. Schneider RJ, Firestone MH, Edelman R, et al. Clinical sequelae after Japanese encephalitis: a one year followup study in Thailand. Southeast Asian J Trop Med Public Health 1974; 5: 560-8.
11. Thongcharoen P. Japanese encephalitis virus encephalitis. Southeast Asian J Trop Med Public Health 1989; 20: 559-73.
12. Tsai TF, Yu YX. Japanese encephalitis vaccines. In: Plotkin S, Mortimers E, eds. Vaccines. WB Saunders. 1994; pp 671-713.
13. Viriyavejakul A, Poungvarin N. Vanadurongwan S. Japanese B encephalitis; clinical aspects of 96 cases. Siriraj Hosp Gaz 1984; 36: 353-60.